Radiofrequency Ablation for Adenomyosis.
Ioannis DedesGeorgios KolovosFruscalzo ArrigoDavid ToubCloé VaineauSusanne LanzSara ImbodenAnis FekiMichael D MuellerPublished in: Journal of clinical medicine (2023)
Adenomyosis is a common benign gynecologic condition characterized by ectopic endometrial glands and stroma in the myometrium causing pain (dysmenorrhea) and abnormal uterine bleeding. New interventional techniques have been introduced over recent years. This study evaluates the treatment success and side effects of radiofrequency ablation. An electronic literature search in the PubMed, Scopus, and ScienceDirect databases was carried out on the outcomes of pain reduction and, secondarily, on abnormal uterine bleeding, reintervention, reproductive outcome, imaging outcome, and complications. There was a mean decrease in dysmenorrhea pain scores by -63.4 ± 9.0% at 12 months. Data on other outcome parameters were sparse. No major complications were reported. Radiofrequency ablation represents a promising minimally invasive and organ-preserving treatment in patients with symptomatic adenomyosis. It is associated with clinically meaningful improvement of adenomyosis-related pain in the short term.
Keyphrases
- radiofrequency ablation
- chronic pain
- pain management
- neuropathic pain
- minimally invasive
- systematic review
- atrial fibrillation
- high resolution
- big data
- spinal cord injury
- endometrial cancer
- type diabetes
- artificial intelligence
- metabolic syndrome
- skeletal muscle
- deep learning
- photodynamic therapy
- insulin resistance
- drug induced